MedPath
TGA Approval

SL NAD+ (451685)

451685

SL NAD+

iX Biopharma Pty Ltd

June 11, 2024

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

nadide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SL NAD+ (451685) - TGA 批准文号 | MedPath